Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

XBiotech Inc. XBIT

Set alert

Price alert · XBIT

All alert types
1.88 USD -0.06 -3.09%

At close · Oct 30

1.88 0.00 0.00%

After hours · Oct 30, 4:00 PM ET

Bid
1.88 × 2
Ask
1.94 × 2
1.87 Day range 1.98
1.85 52-week range 2.94
YTD
-21.34%
1 year
-21.67%
Open
1.94
Prev close
1.94
Mkt cap
57.32M
Vol
50.56K
Avg vol
55.49K
EPS
-1.48
P/E
0.00
Div yield
0.00%
More statistics
Low
1.87
High
1.98
Forward P/E
34.62
Beta
0.00
Short ratio
15.03
Inst. own
16.19%
Dividend
0.00
Ex-div date
Jul 14, 2021
Earnings
Nov 9, 2023
50-d avg
7.07
200-d avg
7.11
1y target
0.00

MAX chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Apr 7, 2020Rating: Piper Sandler · — → Overweight
Signals (35)
NameDateAgo
SMA: BearishMay 1, 20266 months ago
SMA: BullishApr 1, 20267 months ago
MACD: Buy SignalApr 1, 20267 months ago
MACD: Sell SignalJan 1, 20251 year ago
SMA: BearishDec 1, 20241 year ago
SMA: BearishDec 1, 20241 year ago
SMA: BullishJul 1, 20242 years ago
SMA: BullishJul 1, 20242 years ago
SMA: BearishJun 1, 20242 years ago
SMA: BearishJun 1, 20242 years ago
SMA: BullishFeb 1, 20242 years ago
SMA: BullishJan 1, 20242 years ago
SMA: BearishSep 1, 20233 years ago
SMA: BullishMay 1, 20233 years ago
MACD: Buy SignalMay 1, 20233 years ago
RSI: OversoldSep 1, 20224 years ago
SMA: BearishSep 1, 20215 years ago
MACD: Sell SignalApr 1, 20215 years ago
SMA: BearishMar 1, 20215 years ago
SMA: BullishJan 1, 20215 years ago
SMA: BearishDec 1, 20205 years ago
SMA: BullishJul 1, 20206 years ago
SMA: BearishJun 1, 20206 years ago
SMA: BullishApr 1, 20206 years ago
SMA: BearishMar 1, 20206 years ago
RSI: OverboughtDec 1, 20196 years ago
SMA: BullishFeb 1, 20197 years ago
SMA: BullishNov 1, 20188 years ago
MACD: Buy SignalJun 1, 20188 years ago
SMA: BearishMay 1, 20188 years ago
SMA: BullishMar 1, 20188 years ago
SMA: BearishApr 1, 20179 years ago
SMA: BullishMar 1, 20179 years ago
SMA: BearishDec 1, 20169 years ago
SMA: BullishApr 1, 201610 years ago

Financial health

Altman Z-Score

4.98 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B-2 / 5 overall

  • DCF 5
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 5

Valuation

P/E -1.6×
FY 2016: -6.2×FY 2017: -4.1×FY 2018: -8.6×FY 2019: 1.1×FY 2020: -43.5×FY 2021: -19.2×FY 2022: -3.2×FY 2023: -4.9×FY 2024: -3.1×FY 2025: -1.6×
FY 2016 5y median -3.2× FY 2025
P/S 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 11.0×FY 2021: 18.2×FY 2022: 26.6×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 0.5×
FY 2016: 5.6×FY 2017: 2.3×FY 2018: 4.4×FY 2019: 1.0×FY 2020: 1.4×FY 2021: 1.2×FY 2022: 0.4×FY 2023: 0.6×FY 2024: 0.7×FY 2025: 0.5×
FY 2016 5y median 0.6× FY 2025
P/FCF -1.8×
FY 2016: -5.5×FY 2017: -3.9×FY 2018: -10.9×FY 2019: -39.3×FY 2020: -7.0×FY 2021: 5.1×FY 2022: -6.9×FY 2023: -6.4×FY 2024: -3.7×FY 2025: -1.8×
FY 2016 5y median -3.7× FY 2025
EV/EBITDA 1.2×
FY 2016: -5.6×FY 2017: -3.2×FY 2018: -8.9×FY 2019: 0.0×FY 2020: -15.3×FY 2021: -4.3×FY 2022: 1.6×FY 2023: 3.5×FY 2024: 1.2×FY 2025: 1.2×
FY 2016 5y median 1.2× FY 2025
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 5.6×FY 2021: 5.3×FY 2022: -12.6×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -55.2%
FY 2016: -18.3%FY 2017: -25.5%FY 2018: -9.2%FY 2019: -2.5%FY 2020: -14.3%FY 2021: 19.7%FY 2022: -14.4%FY 2023: -15.7%FY 2024: -26.8%FY 2025: -55.2%
FY 2016 5y median -15.7% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 21.5%FY 2021: 68.4%FY 2022: 83.8%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -41.5%FY 2021: -136.4%FY 2022: -860.1%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -25.5%FY 2021: -94.7%FY 2022: -820.4%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -32.4%
FY 2016: -89.3%FY 2017: -55.1%FY 2018: -51.1%FY 2019: 88.5%FY 2020: -3.2%FY 2021: -6.5%FY 2022: -13.7%FY 2023: -11.2%FY 2024: -21.1%FY 2025: -32.4%
FY 2016 5y median -13.7% FY 2025
ROIC -39.2%
FY 2016: -89.3%FY 2017: -56.6%FY 2018: -50.7%FY 2019: -3.8%FY 2020: -4.6%FY 2021: -6.3%FY 2022: -14.0%FY 2023: -17.0%FY 2024: -21.8%FY 2025: -39.2%
FY 2016 5y median -17.0% FY 2025
ROA -30.3%
FY 2016: -78.7%FY 2017: -52.6%FY 2018: -47.7%FY 2019: 81.9%FY 2020: -3.2%FY 2021: -6.3%FY 2022: -13.4%FY 2023: -10.8%FY 2024: -19.4%FY 2025: -30.3%
FY 2016 5y median -13.4% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -58.2%FY 2022: -78.2%FY 2023: -100.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income -31.1%
FY 2016: -40.7%FY 2017: 35.4%FY 2018: 38.4%FY 2019: -48.8%FY 2020: 41.5%FY 2021: -37.2%FY 2022: -37.5%FY 2023: -8.8%FY 2024: -13.2%FY 2025: -31.1%
FY 2016 FY 2025
EPS (diluted) -18.3%
FY 2016: -33.6%FY 2017: 41.7%FY 2018: 37.9%FY 2019: 2547.5%FY 2020: -102.5%FY 2021: -61.1%FY 2022: -86.2%FY 2023: 25.0%FY 2024: -55.6%FY 2025: -18.3%
FY 2016 FY 2025
Free Cash Flow -24.6%
FY 2016: -37.1%FY 2017: 41.5%FY 2018: 52.5%FY 2019: -10.9%FY 2020: -272.8%FY 2021: 195.7%FY 2022: -123.4%FY 2023: -23.9%FY 2024: -69.1%FY 2025: -24.6%
FY 2016 FY 2025

Financial Health

Current Ratio 16.0×
FY 2016: 4.6×FY 2017: 11.9×FY 2018: 5.8×FY 2019: 11.9×FY 2020: 81.8×FY 2021: 71.5×FY 2022: 54.1×FY 2023: 33.1×FY 2024: 11.6×FY 2025: 16.0×
FY 2016 5y median 33.1× FY 2025
Quick Ratio 16.0×
FY 2016: 4.6×FY 2017: 11.9×FY 2018: 5.8×FY 2019: 11.9×FY 2020: 81.8×FY 2021: 71.5×FY 2022: 54.1×FY 2023: 33.1×FY 2024: 11.6×FY 2025: 16.0×
FY 2016 5y median 33.1× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.1×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 2.9×
FY 2016: 0.7×FY 2017: 1.0×FY 2018: 0.8×FY 2019: -1.0×FY 2020: 14.8×FY 2021: 10.4×FY 2022: 5.1×FY 2023: 8.9×FY 2024: 4.5×FY 2025: 2.9×
FY 2016 5y median 5.1× FY 2025
Interest Coverage -633×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: -52.6×FY 2025: -633×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 22.4%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -430.7%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31